Quetiapine

CAS : 111974-69-7

Ref. 3D-FQ32483

Informations sur le produit

• Nom: Quetiapine
• Synonymes: 11-[4-[2-(2-Hydroxyethoxy)Ethyl]-1-Piperazinyl]Dibenzo[B,F][1,4]Thiazepine, 2-(2-(4-Dibenzo(b,f)(1,4)thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethoxy]ethanol (2E)-but-2-enedioate (2:1) (salt), 2-{2-4-(Dibenzob,F1,4Thiazepin-11-Yl)Piperazin-1-Ylethoxy}Ethanol, 2-{2-[4-(Dibenzo[b,f][1,4]thiazepin-11-yl)-1-piperazinyl]ethoxy}ethanol, 2-{2-[4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl]ethoxy}ethanol, 2-{[2-(4-Dibenzo[B,F][1,4]Thiazepin-11-Ylpiperazin-1-Yl)Ethyl]Oxy}Ethanol, Dibenzo[b,f][1,4]thiazepine, ethanol deriv., Ethanol, 2-2-(4-Dibenzob,F1,4Thiazepin-11-Yl-1-Piperazinyl)Ethoxy-, Ethanol, 2-[2-(4-Dibenzo[B,F][1,4]Thiazepin-11-Yl-1-Piperazinyl)Ethoxy]-, Ketipinor, Seronia

Description

Quetiapine is a psychotropic drug that belongs to the class of atypical antipsychotics. It is used in the treatment of schizophrenia and bipolar disorder. Quetiapine has been shown to have a potent inhibitory effect on prolactin levels, which may be due to its ability to induce fumarate reductase and increase blood flow to the hypothalamus. Quetiapine also interacts with a number of other drugs and can lead to adverse reactions when taken with them. The clinical efficacy of quetiapine for schizophrenia was demonstrated by a double-blind, randomized, placebo-controlled trial involving over 400 patients. The therapeutic efficacy of quetiapine has also been demonstrated in treatment trials involving patients with acute mania associated with bipolar disorder and schizoaffective disorder.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 383.51 g/mol
• Formule: C₂₁H₂₅N₃O₂S
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder
• InChI: InChI=1S/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2
• Code InChI: InChIKey=URKOMYMAXPYINW-UHFFFAOYSA-N
• SMILES: OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1